关注
Jon Rasmussen
Jon Rasmussen
其他姓名Jon Bjarke Rasmussen, Jon Jarløv Rasmussen
MD, PhD, Department of Endocrinology, Rigshospitalet
在 dadlnet.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre …
A Jorsal, C Kistorp, P Holmager, RS Tougaard, R Nielsen, A Hänselmann, ...
European journal of heart failure 19 (1), 69-77, 2017
4272017
Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study
JJ Rasmussen, C Selmer, PB Østergren, KB Pedersen, M Schou, ...
PloS one 11 (8), e0161208, 2016
1682016
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?
JJ Rasmussen, M Schou, PL Madsen, C Selmer, ML Johansen, P Hovind, ...
Journal of hypertension 36 (2), 277-285, 2018
752018
Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids
JJ Rasmussen, M Schou, PL Madsen, C Selmer, ML Johansen, ...
American heart journal 203, 49-56, 2018
582018
Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids
JJ Rasmussen, M Schou, C Selmer, ML Johansen, F Gustafsson, ...
Clinical endocrinology 87 (3), 249-256, 2017
552017
Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis
M Paquette, D Gauthier, A Chamberland, A Prat, EDL Rolfe, ...
Clinical biochemistry 77, 20-25, 2020
362020
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation
M Refsgaard Holm, H Christensen, J Rasmussen, ML Johansen, M Schou, ...
ESC Heart Failure 6 (5), 983-991, 2019
282019
Procoagulant state in current and former anabolic androgenic steroid abusers
S Chang, JJ Rasmussen, MN Frandsen, M Schou, ML Johansen, J Faber, ...
Thrombosis and Haemostasis 118 (04), 647-653, 2018
262018
Iron deficiency: prevalence and relation to cardiovascular biomarkers in heart failure outpatients
M Schou, H Bosselmann, F Gaborit, K Iversen, JP Goetze, G Soletomas, ...
International journal of cardiology 195, 143-148, 2015
252015
The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 …
R Nielsen, A Jorsal, RS Tougaard, JJ Rasmussen, M Schou, L Videbæk, ...
Diabetes, Obesity and Metabolism 22 (11), 2141-2150, 2020
212020
Endogenous testosterone levels are associated with risk of type 2 diabetes in women without established comorbidity
JJ Rasmussen, C Selmer, S Frøssing, M Schou, J Faber, ...
Journal of the Endocrine Society 4 (6), bvaa050, 2020
212020
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity …
JB Rasmussen, JD Knudsen, M Arpi, HC Schønheyder, T Benfield, ...
Journal of Antimicrobial Chemotherapy 69 (2), 506-514, 2014
212014
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: data from the …
NH Brandt-Jacobsen, ML Johansen, J Rasmussen, JL Forman, MR Holm, ...
Diabetes & metabolism 47 (4), 101190, 2021
192021
Random blood glucose may be used to assess long‐term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting
JB Rasmussen, LS Nordin, NS Rasmussen, JA Thomsen, LA Street, ...
Tropical Medicine & International Health 19 (12), 1515-1519, 2014
192014
Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled …
L Thorlacius-Ussing, H Sandholdt, J Nissen, J Rasmussen, R Skov, ...
Clinical Infectious Diseases 73 (5), 866-872, 2021
182021
Mineralocorticoid receptor antagonist improves cardiac structure in type 2 diabetes: data from the MIRAD trial
NH Brandt-Jacobsen, P Lav Madsen, ML Johansen, JJ Rasmussen, ...
Heart Failure 9 (8), 550-558, 2021
182021
An abductive inference approach to assess the performance-enhancing effects of drugs included on the World Anti-Doping Agency prohibited list
A Breenfeldt Andersen, GA Jacobson, J Bejder, D Premilovac, ...
Sports Medicine 51 (7), 1353-1376, 2021
182021
Serum insulin-like factor 3 levels are reduced in former androgen users, suggesting impaired Leydig cell capacity
JJ Rasmussen, J Albrethsen, MN Frandsen, N Jørgensen, A Juul, ...
The Journal of Clinical Endocrinology & Metabolism 106 (7), e2664-e2672, 2021
182021
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled …
ML Johansen, M Schou, P Rossignol, MR Holm, J Rasmussen, N Brandt, ...
Diabetes, Obesity and Metabolism 21 (10), 2305-2314, 2019
182019
Hemoglobin levels and blood pressure are associated in rural black africans
JB Rasmussen, DL Mwaniki, LU Kaduka, MK Boit, K Borch‐Johnsen, ...
American Journal of Human Biology 28 (1), 145-148, 2016
162016
系统目前无法执行此操作,请稍后再试。
文章 1–20